This clip device repairs leaky mitral valves without open-heart surgery and is delivered to the heart through a vein in the leg. The device clips portions of the leaflets, or flaps, of the mitral valve together to reduce the backflow of blood (known as mitral regurgitation, or MR), restoring the heart’s ability to pump oxygenated blood more efficiently. To date, this product has helped treat more than 100,000 people worldwide suffering from MR and is supported by the industry’s most extensive body of clinical evidence, including the results of the landmark COAPT™ Trial published in The New England Journal of Medicine in September 2018. In addition, the device’s safety and efficacy is also supported by 3 randomized clinical trials, over 30,000 people enrolled in clinical studies and 1000+ publications. With more than 16 years of clinical experience, Abbott’s mitral clip system is the first and only transcatheter mitral valve therapy with proven safety and survival, and durability of clinical outcomes.
Cardiac ailments affect more people than any other non-communicable disease in India. According to a study by The Lancet, cardiovascular diseases caused 28 percent of deaths in 2016, which was double the numbers reported in 1990 when it caused 15 percent of deaths in the country – from 1.3 million in 1990 to 2.8 million in 2016 in India.
Dr. Ravinder Singh Rao, Director, TAVI and Structural Heart Disease Program, Consultant Interventional Structural Cardiologist, Eternal Hospital, Jaipur said, “Mitral regurgitation with poor left ventricular function carries a poor prognosis. Medicines alone cannot cure this mechanical problem, and only help the heart tolerate it better. Open heart surgeries have risks for some patients.” Talking about two recent procedures that he performed, Dr. Rao added, “I used the clip technology on two patients last week. One was a 56-year-old woman with poor LV function and severe mitral regurgitation, while the second patient was a 72-year-old doctor who had poor LV function and MR. He had in fact had a heart attack in the past. Post procedure both patients are better, and we could confirm leakage reduction on the transesophageal echocardiogram. The procedure is safe and effective. Medical innovations such as these give our patients better odds at long-term survival and improved quality of life.”